NCT01023802View on ClinicalTrials.gov

The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Neoadjuvant TherapyChemotherapyHormone Replacement TherapyBreast Cancer
Trial Locations (1)

55905

Mayo Clinic - Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT01023802 - The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer | Biotech Hunter | Biotech Hunter